跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIVTENCITY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIVTENCITY
Authorized
STANDARD
LIVTENCITY
takeda canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b09bbf762c580d98
Company
takeda canada inc
Type
Standard
Approval Details
Approval Id
b09bbf762c580d98
Drug Approval Canada Name
LIVTENCITY
Product Name
LIVTENCITY
Status
Marketed
Status Date
2022-10-25
Original Market Date
2022-10-25
Din
02530740
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.92
Atc Original
J05AX10 MARIBAVIR
Atc Name
j 05 ax 10
Aig Number
0164061001
Company Name
takeda canada inc
Company Address
3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3
Active Ingredients
MARIBAVIR
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b09bbf762c580d98
Type
Standard
Back to Health Canada Approvals